Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives (†)

Therapeutic agents targeting bacterial virulence factors are gaining interest as non-antibiotic alternatives for the treatment of infectious diseases. Clostridium difficile is a Gram-positive pathogen that produces two primary virulence factors, enterotoxins A and B (TcdA and TcdB), which are respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussack, Greg, Tanha, Jamshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153223/
https://www.ncbi.nlm.nih.gov/pubmed/22069622
http://dx.doi.org/10.3390/toxins2050998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153223/
https://www.ncbi.nlm.nih.gov/pubmed/22069622
http://dx.doi.org/10.3390/toxins2050998

Ejemplares similares